Prevention of complications of varicose veins of pelvic organs in women of reproductive age

This research aimed to evaluate the effectiveness of Dioflan, the venotonic and radioprotector, in the treatment of pregnant women's varicose disease and its complications. We observed 25 women with the varicose disease (Chronic Venous Insufficiency-0-I) in the 3rd trimester of pregnancy. All women passed duplex angioscanning with small vessels color Doppler mapping and Doppler metric examination of the uterine-fetus-placenta blood circulation. It was established that 70.8% of pregnant women with the varicose disease of the lower extremities had varicosity of the uterine veins. In 64, 6% of observations, we diagnosticated the hemodynamic disorders in the system of the uterine-fetus-placental blood circulation of the pregnant women with varicosity in the 3rd trimester. Against Flebodia 600, 79, 2% of patients showed the regression of clinic symptoms of Chronic Venous Insufficiency, as well as 66.7%, gave the normalization of indices for uterine-fetus-placenta hemodynamics. Thus, Dioflan, the venotonic and angioptrotector, provides a many-sided effect to the venous system of lower extremities and the pregnant women's, having the varicose disease, hemodynamics state of uterine-fetusplacental blood flow, stimulating the reduction of disorders in the course of pregnancy and childbirth.